ANTAGONISTAS DEL RECEPTOR CRTH2 BASADOS EN INDOL
Se desvelan compuestos de Fórmula (I), que son útiles como antagonistas de los receptores CRTH2. También se desvelan composiciones farmacéuticas que contienen compuestos de Fórmula(I) y el uso de compuestos de Fórmula (I) para tratar enfermedades o trastornos que son sensibles a la inhibición de la...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KRISTIN MARIE JANZ KAILA NEELU MICHAEL DENNIS LOWE SAIAH EDDINE TAREK SUHAYL MANSOUR HUANG ADRIAN ALESSANDRO FABIO MORETTO JENNIFER ROMANIC THOMASON CARA MARGARET MAY WILLIAMS BRUCE CHRISTOPHER FOLLOWS |
| description | Se desvelan compuestos de Fórmula (I), que son útiles como antagonistas de los receptores CRTH2. También se desvelan composiciones farmacéuticas que contienen compuestos de Fórmula(I) y el uso de compuestos de Fórmula (I) para tratar enfermedades o trastornos que son sensibles a la inhibición de la unión de ligandos endógenos al receptorCRTH2. También se describen procedimientos para preparar y usar estos compuestos.
Disclosed are compounds of Formula (I): which are useful as antagonists of the CRTH2 receptors. Pharmaceutical compositions containing compounds of Formula (I) and the use of compounds of Formula (I) to treat diseases or disorders that are responsive to inhibition of the binding of endogenous ligands to the CRTH2 receptor are also disclosed. Methods for preparing and using these compounds are further described. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UY32996A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UY32996A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UY32996A3</originalsourceid><addsrcrecordid>eNrjZDBw9AtxdPf38wwOcQxWcHH1UQhydXYNCPEPUnAOCvEwUnByDHZ08Q9WcPVT8PRz8ffhYWBNS8wpTuWF0twMsm6uIc4euqkF-fGpxQWJyal5qSXxoZHGRpaWZo7GhOQB_hwksQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTAGONISTAS DEL RECEPTOR CRTH2 BASADOS EN INDOL</title><source>esp@cenet</source><creator>KRISTIN MARIE JANZ ; KAILA NEELU ; MICHAEL DENNIS LOWE ; SAIAH EDDINE ; TAREK SUHAYL MANSOUR ; HUANG ADRIAN ; ALESSANDRO FABIO MORETTO ; JENNIFER ROMANIC THOMASON ; CARA MARGARET MAY WILLIAMS ; BRUCE CHRISTOPHER FOLLOWS</creator><creatorcontrib>KRISTIN MARIE JANZ ; KAILA NEELU ; MICHAEL DENNIS LOWE ; SAIAH EDDINE ; TAREK SUHAYL MANSOUR ; HUANG ADRIAN ; ALESSANDRO FABIO MORETTO ; JENNIFER ROMANIC THOMASON ; CARA MARGARET MAY WILLIAMS ; BRUCE CHRISTOPHER FOLLOWS</creatorcontrib><description>Se desvelan compuestos de Fórmula (I), que son útiles como antagonistas de los receptores CRTH2. También se desvelan composiciones farmacéuticas que contienen compuestos de Fórmula(I) y el uso de compuestos de Fórmula (I) para tratar enfermedades o trastornos que son sensibles a la inhibición de la unión de ligandos endógenos al receptorCRTH2. También se describen procedimientos para preparar y usar estos compuestos.
Disclosed are compounds of Formula (I): which are useful as antagonists of the CRTH2 receptors. Pharmaceutical compositions containing compounds of Formula (I) and the use of compounds of Formula (I) to treat diseases or disorders that are responsive to inhibition of the binding of endogenous ligands to the CRTH2 receptor are also disclosed. Methods for preparing and using these compounds are further described.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110630&DB=EPODOC&CC=UY&NR=32996A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110630&DB=EPODOC&CC=UY&NR=32996A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KRISTIN MARIE JANZ</creatorcontrib><creatorcontrib>KAILA NEELU</creatorcontrib><creatorcontrib>MICHAEL DENNIS LOWE</creatorcontrib><creatorcontrib>SAIAH EDDINE</creatorcontrib><creatorcontrib>TAREK SUHAYL MANSOUR</creatorcontrib><creatorcontrib>HUANG ADRIAN</creatorcontrib><creatorcontrib>ALESSANDRO FABIO MORETTO</creatorcontrib><creatorcontrib>JENNIFER ROMANIC THOMASON</creatorcontrib><creatorcontrib>CARA MARGARET MAY WILLIAMS</creatorcontrib><creatorcontrib>BRUCE CHRISTOPHER FOLLOWS</creatorcontrib><title>ANTAGONISTAS DEL RECEPTOR CRTH2 BASADOS EN INDOL</title><description>Se desvelan compuestos de Fórmula (I), que son útiles como antagonistas de los receptores CRTH2. También se desvelan composiciones farmacéuticas que contienen compuestos de Fórmula(I) y el uso de compuestos de Fórmula (I) para tratar enfermedades o trastornos que son sensibles a la inhibición de la unión de ligandos endógenos al receptorCRTH2. También se describen procedimientos para preparar y usar estos compuestos.
Disclosed are compounds of Formula (I): which are useful as antagonists of the CRTH2 receptors. Pharmaceutical compositions containing compounds of Formula (I) and the use of compounds of Formula (I) to treat diseases or disorders that are responsive to inhibition of the binding of endogenous ligands to the CRTH2 receptor are also disclosed. Methods for preparing and using these compounds are further described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9AtxdPf38wwOcQxWcHH1UQhydXYNCPEPUnAOCvEwUnByDHZ08Q9WcPVT8PRz8ffhYWBNS8wpTuWF0twMsm6uIc4euqkF-fGpxQWJyal5qSXxoZHGRpaWZo7GhOQB_hwksQ</recordid><startdate>20110630</startdate><enddate>20110630</enddate><creator>KRISTIN MARIE JANZ</creator><creator>KAILA NEELU</creator><creator>MICHAEL DENNIS LOWE</creator><creator>SAIAH EDDINE</creator><creator>TAREK SUHAYL MANSOUR</creator><creator>HUANG ADRIAN</creator><creator>ALESSANDRO FABIO MORETTO</creator><creator>JENNIFER ROMANIC THOMASON</creator><creator>CARA MARGARET MAY WILLIAMS</creator><creator>BRUCE CHRISTOPHER FOLLOWS</creator><scope>EVB</scope></search><sort><creationdate>20110630</creationdate><title>ANTAGONISTAS DEL RECEPTOR CRTH2 BASADOS EN INDOL</title><author>KRISTIN MARIE JANZ ; KAILA NEELU ; MICHAEL DENNIS LOWE ; SAIAH EDDINE ; TAREK SUHAYL MANSOUR ; HUANG ADRIAN ; ALESSANDRO FABIO MORETTO ; JENNIFER ROMANIC THOMASON ; CARA MARGARET MAY WILLIAMS ; BRUCE CHRISTOPHER FOLLOWS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UY32996A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KRISTIN MARIE JANZ</creatorcontrib><creatorcontrib>KAILA NEELU</creatorcontrib><creatorcontrib>MICHAEL DENNIS LOWE</creatorcontrib><creatorcontrib>SAIAH EDDINE</creatorcontrib><creatorcontrib>TAREK SUHAYL MANSOUR</creatorcontrib><creatorcontrib>HUANG ADRIAN</creatorcontrib><creatorcontrib>ALESSANDRO FABIO MORETTO</creatorcontrib><creatorcontrib>JENNIFER ROMANIC THOMASON</creatorcontrib><creatorcontrib>CARA MARGARET MAY WILLIAMS</creatorcontrib><creatorcontrib>BRUCE CHRISTOPHER FOLLOWS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KRISTIN MARIE JANZ</au><au>KAILA NEELU</au><au>MICHAEL DENNIS LOWE</au><au>SAIAH EDDINE</au><au>TAREK SUHAYL MANSOUR</au><au>HUANG ADRIAN</au><au>ALESSANDRO FABIO MORETTO</au><au>JENNIFER ROMANIC THOMASON</au><au>CARA MARGARET MAY WILLIAMS</au><au>BRUCE CHRISTOPHER FOLLOWS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTAGONISTAS DEL RECEPTOR CRTH2 BASADOS EN INDOL</title><date>2011-06-30</date><risdate>2011</risdate><abstract>Se desvelan compuestos de Fórmula (I), que son útiles como antagonistas de los receptores CRTH2. También se desvelan composiciones farmacéuticas que contienen compuestos de Fórmula(I) y el uso de compuestos de Fórmula (I) para tratar enfermedades o trastornos que son sensibles a la inhibición de la unión de ligandos endógenos al receptorCRTH2. También se describen procedimientos para preparar y usar estos compuestos.
Disclosed are compounds of Formula (I): which are useful as antagonists of the CRTH2 receptors. Pharmaceutical compositions containing compounds of Formula (I) and the use of compounds of Formula (I) to treat diseases or disorders that are responsive to inhibition of the binding of endogenous ligands to the CRTH2 receptor are also disclosed. Methods for preparing and using these compounds are further described.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_UY32996A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANTAGONISTAS DEL RECEPTOR CRTH2 BASADOS EN INDOL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A14%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KRISTIN%20MARIE%20JANZ&rft.date=2011-06-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUY32996A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |